Tue, May 22, 2012
Bavarian Nordic says U.S. backs new Imvamune study
COPENHAGEN (Reuters) - Danish biopharma firm Bavarian Nordic said on Tuesday that the U.S. Department of Health and Human Services has supported the initiation ...
Tue, May 22, 2012
Ramadan sets Muslim athletes extra test at London Games
By Kate Kelland, Health and Science Correspondent
LONDON (Reuters)- When Malaysian cyclist Azizulhasni Awang opted to postpone his Ramadan fast until after the London ...
Mon, May 21, 2012
Fake drugs threaten gains made in war on malaria
By Kate Kelland
LONDON (Reuters) - Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains ...
Mon, May 21, 2012
U.S. Catholic groups sue to block contraception mandate
By Terry Baynes
(Reuters) - The University of Notre Dame and dozens of other Catholic institutions sued President Barack Obama's administration on Monday to ...
Mon, May 21, 2012
U.S. task force: End routine prostate cancer screening
By Sharon Begley
NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening ...
Mon, May 21, 2012
Tired surgical residents may up error risk: study
By Andrew M. Seaman
NEW YORK (Reuters Health) - A small study suggests surgeons in training are still tired enough to raise their risk of ...
Mon, May 21, 2012
Lung cancer tests advised for some heavy smokers
By Genevra Pittman
NEW YORK (Reuters Health) - New recommendations from chest and cancer doctors call for lung cancer screening in older adults with a ...
Mon, May 21, 2012
Not all ICUs need a specialist at night: study
By Kerry Grens
NEW YORK (Reuters Health) - Among hospital intensive care units (ICUs) with a daytime physician specially trained in critical care, adding a ...
Mon, May 21, 2012
"Pre-diabetes," diabetes rising among U.S. teens
By Amy Norton NEW YORK (Reuters Health) - The percentage of U.S. teenagers with "pre-diabetes" or full-blown type 2 diabetes has more than doubled ...
Mon, May 21, 2012
Peregrine soars as cancer drug meets trial goal
(Reuters) - Peregrine Pharmaceuticals Inc said results from a mid-stage trial showed that its key experimental drug performed better than standard chemotherapy in lung cancer ...
Recent Comments